Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
ConclusionGlucose intolerance (e.g., HbA1c level ≥ 5.8%) may be a risk factor of cytotoxic chemotherapy-induced lung injury, which might be associated with elevated AGE production due to hyperglycemia.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Interstitial Lung Disease | Lung Cancer